噬菌體市場規模、佔有率和成長分析（按產品類型、給藥途徑、分銷管道、應用、最終用途行業和地區）- 2025-2032 年行業預測

2023 年全球噬菌體市場規模為 4,960 萬美元，預計將從 2024 年的 5,243 萬美元成長到 2032 年的 8,169 萬美元，預測期內（2025-2032 年）的複合年成長率為 5.7%。

全球噬菌體市場正在成為對抗抗生素抗藥性和細菌感染的關鍵解決方案。噬菌體是一種特異性針對細菌的病毒，是傳統抗生素的有希望的替代品。人們對抗生素抗藥性細菌這一全球健康威脅的擔憂日益加劇，刺激了市場的成長。噬菌體因其高度特異性、與細菌共同進化的能力以及對有益微生物群的干擾最小而受到廣泛歡迎。噬菌體療法在臨床前和臨床試驗中都表現出了良好的效果，並且某些地區的監管核准增加了其市場可行性。隨著製藥公司和研究機構之間的合作加強，市場將會擴大，透過提供個人化的治療方案和降低抗藥性風險，噬菌體將成為抗生素領域的關鍵參與者。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究

噬菌體市場規模（依產品類型和複合年成長率） (2025-2032)

• 市場概況
• 噬菌體益生菌
• 噬菌體治療公司

噬菌體市場規模（依給藥途徑及複合年成長率） (2025-2032)

• 市場概況
• 口服
• 外用藥物
• 其他

噬菌體市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 零售藥局
• 醫院藥房
• 網路藥局

噬菌體市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 胃腸病學
• 治療呼吸道感染疾病
• 治療皮膚感染疾病
• 傷口預防
• 泌尿系統感染疾病的治療

噬菌體市場規模（以最終用途產業和複合年成長率分類）（2025-2032 年）

• 市場概況
• 醫院
• 專科門診
• 居家護理
• 其他

噬菌體市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Intralytix（United States）
• Proteon Pharmaceuticals（Poland）
• Phagelux（China）
• Micreos（Netherlands）
• Eliava BioPreparations（Georgia）
• Locus Biosciences（United States）
• Pherecydes Pharma（France）
• APS Biocontrol Ltd.（United Kingdom）
• Qingdao Phagepharm Biotech（China）
• Fixed-Phage Limited（United Kingdom）
• Zeptometrix（United States）
• Phage International, Inc.（United States）
• Micromir（Russia）
• Armata Pharmaceuticals, Inc.（United States）
• Nextbiotics（United States）
• InnoPhage, Ltd（Portugal）
• TechnoPhage（Portugal）
• Eligo Bioscience SA（France）
• NPO Microgen（Russia）
• Pharmex Group, LLC（Russia）

結論和建議

Global Bacteriophage Market size was valued at USD 49.6 million in 2023 and is poised to grow from USD 52.43 million in 2024 to USD 81.69 million by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global bacteriophage market is emerging as a vital solution to antibiotic resistance and bacterial infections. Bacteriophages, which are viruses that specifically target bacteria, present a promising alternative to conventional antibiotics. The market's growth is fueled by increasing concerns over antibiotic-resistant bacteria, which are a significant global health threat. With their high specificity, capacity to evolve alongside bacteria, and minimal disruption to beneficial microbiota, bacteriophages are gaining traction. Phage therapy has shown encouraging results in both preclinical and clinical trials, and regulatory approvals in certain regions are enhancing market viability. As collaboration between pharmaceutical companies and research institutions intensifies, the market is poised for expansion, providing personalized treatment options and reducing resistance risks, thereby positioning bacteriophages as critical players in the antimicrobial landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacteriophage market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacteriophage Market Segments Analysis

Global Bacteriophage Market is segmented by Product Type, Route of Administration, Distribution Channel, Application, End-use Industry and region. Based on Product Type, the market is segmented into Phage Probiotics and Phage Therapeutics. Based on Route of Administration, the market is segmented into Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Gastroenterology, Respiratory Infections Treatment, Skin Infection Treatment, Wound Prophylaxis and Urological Infection Treatment. Based on End-use Industry, the market is segmented into Hospitals, Specialty Clinics, Homecare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacteriophage Market

The rising incidence of antibiotic-resistant bacterial infections is significantly boosting the demand for alternative treatment solutions. Bacteriophages, which are viruses specifically designed to target and eliminate certain bacteria, present a compelling option for tackling antibiotic-resistant strains and superbugs. With traditional antibiotics becoming less effective, the global bacteriophage market is experiencing growth driven by the necessity for novel and tailored therapeutic strategies. This shift towards bacteriophage therapy highlights the urgent need for innovative solutions in the face of mounting challenges posed by resistant bacteria, ultimately shaping the future of infectious disease management and treatment modalities.

Restraints in the Global Bacteriophage Market

The global bacteriophage market faces significant restraints primarily due to the regulatory challenges associated with the use of live viruses in bacteriophage therapy. These challenges stem from safety concerns that necessitate extensive testing and approval processes to ascertain the safety and efficacy of these products, often leading to time-consuming and expensive procedures. Additionally, the presence of regulatory uncertainties and discrepancies across various regions can further impede the growth and expansion of the market. As a result, these factors may limit the accessibility and acceptance of bacteriophage therapies, ultimately affecting market potential and development.

Market Trends of the Global Bacteriophage Market

The Global Bacteriophage market is witnessing a significant upward trend, propelled by a surging interest in phage therapy amid the escalating crisis of antibiotic resistance. As traditional antibiotics become less effective against harmful bacterial pathogens, the medical community is increasingly turning to bacteriophages, which specifically target and eliminate resistant bacteria. Advances in phage biology, innovative isolation techniques, and successful clinical case studies are enhancing the viability of phage therapy as a therapeutic alternative. This paradigm shift in treating bacterial infections suggests a robust future for the bacteriophage market, estimated to grow exponentially as it addresses unmet medical needs worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Bacteriophage Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Phage Probiotics
• Phage Therapeutics

Global Bacteriophage Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Topical
• Others

Global Bacteriophage Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Bacteriophage Market Size by Application & CAGR (2025-2032)

• Market Overview
• Gastroenterology
• Respiratory Infections Treatment
• Skin Infection Treatment
• Wound Prophylaxis
• Urological Infection Treatment

Global Bacteriophage Market Size by End-use Industry & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare
• Others

Global Bacteriophage Market Size & CAGR (2025-2032)

• North America (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • US
  • Canada
• Europe (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Intralytix (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteon Pharmaceuticals (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phagelux (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micreos (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eliava BioPreparations (Georgia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Locus Biosciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pherecydes Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• APS Biocontrol Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qingdao Phagepharm Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fixed-Phage Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeptometrix (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phage International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micromir (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Armata Pharmaceuticals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nextbiotics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InnoPhage, Ltd (Portugal)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TechnoPhage (Portugal)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eligo Bioscience SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NPO Microgen (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmex Group, LLC (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations